Movers & Shakers: Biogen stock climbs on drug approval recommendation, Oracle shares rise ahead of earnings, and other stocks on the move

Here are some of the biggest movers of Monday.

Stock gainers:

Biogen Inc. shares
BIIB,
+1.31%

rallied 5% following a full-day halt during the regular session as a Food and Drug Administration committee convened to vote on an approval recommendation for the biotech’s Alzheimer’s drug candidate it makes with Eisai Co.
ESALF,
+9.35%

The committee voted unanimously to recommend approval, and Biogen shares took off when they were unhalted.

Oracle Corp.
ORCL,
+2.21%

stock rose 4%. It is slated to report fiscal fourth-quarter earnings after the bell on Monday. Analysts polled by FactSet expect the software giant to report adjusted earnings of $1.58 a share on sales of $13.7 billion.

Teck Resources
TECK,
-0.56%

TECK.B,
-0.54%

stock edged higher as Glencore
GLEN,
+0.25%

lodged a bid for its coal unit, in addition to a $23 billion offer for the whole company.

Stock decliners:

Carvana shares
CVNA,
-21.30%

fell 1%, following a 21% downturn on Friday for the volatile used-car retailer.

This post was originally published on Market Watch

Share:

Futurist Eric Fry says it will be a “Summer of Surge” for these three stocks

One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Watch now…

Latest News

Daily News on Investing, Personal Finance, Markets, and more!

Financial News

Financial News

Daily News on Investing, Personal Finance, Markets, and more!